[New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000077384:Anastrozole; D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D000068579:Celecoxib; D002648:Child; D004311:Double-Blind Method; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D005858:Germany / Q000453:epidemiology; D020249:Hormone Replacement Therapy; D006801:Humans; D007044:Hysterectomy; D008019:Life Style; D008327:Mammography; D008572:Menarche; D008593:Menopause; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D010052:Ovariectomy; D011247:Pregnancy; D011720:Pyrazoles; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D012907:Smoking / Q000009:adverse effects; D013449:Sulfonamides / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*
D016588:Anticarcinogenic Agents; D004965:Estrogen Antagonists; D009570:Nitriles; D011720:Pyrazoles; D020845:Selective Estrogen Receptor Modulators; D013449:Sulfonamides; D014230:Triazoles; D013629:Tamoxifen; D000077384:Anastrozole; D020849:Raloxifene Hydrochloride; D000068579:Celecoxib
Neue Präventionsstrategien genen Brustkrebs und Zervixkarzinom. Was Sie Ihren Patientinnen raten können.